CopyFind
← Back to search
CureVac�s COVID-19 vaccine (CVnCoV)
medicine 📍 EU

CureVac�s COVID-19 vaccine (CVnCoV)

Active Ingredient / Formula: single-stranded, 5�-capped messenger RNA (mRNA) produced using a cell-free in vitro transcription from the corresponding DNA templates, encoding the viral spike (S) protein of SARS-CoV-2

Product Overview

European Union approved medicinal product.
View on EMA official website →

Visitor ratings

Help others by rating how useful this product page is.

No ratings yet — be the first.

Similar Products & Analogs

Comirnaty

single-stranded, 5�-capped messenger RNA produced using a cell-free in vitro transcription from the corresponding DNA templates, encoding the viral spike (S) protein of SARS-CoV-2

mCombriax

single-stranded, 5�-capped messenger RNAs (mRNAs) produced using a cell-free in vitro transcription from the corresponding DNA template, encoding seasonal influenza haemagglutinin (HA) glycoproteins: A/H1N1, A/H3N2, B/Victoria

mNexspike

single-stranded, 5�-capped messenger RNA (mRNA) produced using a cell-free in vitro transcription from the corresponding DNA template, encoding the N-terminal domain and receptor-binding domain of the viral spike (S) protein of SARS-CoV-2

Spikevax (previously COVID-19 Vaccine Moderna)

single-stranded, 5�-capped messenger RNA (mRNA) produced using a cell-free in vitro transcription from the corresponding DNA templates, encoding the viral spike (S) protein of SARS-CoV-2